Genscript Biotech Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 29, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	3,028	2,623	4,883	6,308	8,175	2,323
Market Cap Growth	20.87%	-46.28%	-22.58%	-22.84%	251.89%	-38.84%
Enterprise Value	2,703	2,351	4,403	5,721	7,301	1,564
Last Close Price	1.34	1.20	2.23	2.95	3.56	1.15
PE Ratio	1.14	0.92	-	-	-	-
PS Ratio	4.29	4.57	9.63	10.77	18.97	7.27
PB Ratio	0.80	0.63	2.64	4.95	6.70	3.48
P/TBV Ratio	0.81	0.63	3.94	6.85	9.25	3.30
P/FCF Ratio	27.70	-	-	-	-	-
P/OCF Ratio	15.57	35.90	-	-	-	-
EV/Sales Ratio	3.86	4.09	8.68	9.77	16.94	4.90
EV/EBITDA Ratio	172.50	34.75	58.29	-	-	-
EV/EBIT Ratio	-	262.23	185.81	-	-	-
EV/FCF Ratio	24.72	-	-	-	-	-
Debt / Equity Ratio	0.12	0.17	0.41	0.48	0.30	0.07
Debt / EBITDA Ratio	2.20	8.51	8.59	-	-	-
Debt / FCF Ratio	4.27	-	-	-	-	-
Asset Turnover	0.19	0.14	0.19	0.26	0.27	0.34
Inventory Turnover	8.23	7.64	5.12	6.17	5.46	5.60
Quick Ratio	1.78	2.46	4.50	2.99	3.80	2.85
Current Ratio	1.96	2.72	4.76	3.23	3.97	3.03
Return on Equity (ROE)	-1.94%	-5.46%	9.56%	-31.12%	-47.05%	-47.38%
Return on Assets (ROA)	2.56%	0.13%	0.55%	-11.45%	-12.88%	-10.94%
Return on Invested Capital (ROIC)	4.45%	0.34%	3.34%	-91.80%	-152.50%	-600.56%
Return on Capital Employed (ROCE)	3.70%	0.20%	0.90%	-21.90%	-20.80%	-18.30%
Earnings Yield	87.50%	109.05%	-1.77%	-3.36%	-3.86%	-7.21%
FCF Yield	3.61%	-4.42%	-9.99%	-4.99%	-2.90%	-9.61%
Buyback Yield / Dilution	-4.08%	-3.27%	-0.58%	-3.28%	-6.83%	-2.53%
Total Shareholder Return	-4.08%	-3.27%	-0.58%	-3.28%	-6.83%	-2.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.